| Mrs Janice Marie Schwartz, | |
|
4750 E 450 S, Whitestown, IN 46075-8404 | |
| (877) 783-2262 | |
| (888) 327-9791 |
| Full Name | Mrs Janice Marie Schwartz |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 4750 E 450 S, Whitestown, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104503697 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 26019650A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Janice Marie Schwartz, 4750 E 450 S, Whitestown, IN 46075-8404 Ph: () - | Mrs Janice Marie Schwartz, 4750 E 450 S, Whitestown, IN 46075-8404 Ph: (877) 783-2262 |
News Archive
Data reported by the Hearts Beat Back: The Heart of New Ulm Project reinforce the positive influence of lifestyle factors in mitigating risks that potentially increase the likelihood of heart disease and other health problems. Findings based on 1,059 residents of New Ulm, Minn, underscore the importance of obesity prevention and nutrition, specifically eating more fruits and vegetables, in addressing metabolic syndrome, a common precursor to cardiovascular disease.
Kendle, a leading, global full-service clinical research organization, today announced it now offers Brain Network Activation imaging providing a non-invasive platform for mapping, monitoring and understanding brain electro-physiological network activity in response to cognitive or physiological stimuli. The BNA imaging technology was developed by ElMindA, a medical technology development company based in Herzliya, Israel.
Neuralstem, Inc. announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin two Phase I safety trials to test NSI-189, its first small molecule compound, for the treatment of major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression.
Altos Therapeutics, LLC announced today that the Mexican Institute of Industrial Property has issued Patent Number 323020 titled, "D2 Antagonists, Methods of Synthesis and Methods of Use". The patent broadly and specifically covers the company's dopamine D2/D3 drug candidates, their pharmaceutical compositions, and their use to treat a number of important gastrointestinal conditions in humans, such as gastroparesis.
› Verified 2 days ago
Rachel Marie Opperman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4750 E 450 S, Whitestown, IN 46075 Phone: 219-707-1708 | |
Jacob Pollard, PHARMD, MBA Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4750 E 450 S, Whitestown, IN 46075 Phone: 877-732-3431 | |
Ashley Susan Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4750 E 450 S, Whitestown, IN 46075 Phone: 877-732-3431 | |
Dr. Bryan Dodd, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4750 E 450 S, Whitestown, IN 46075 Phone: 317-569-0387 | |
Kelsey Cahill, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4750 E 450 S, Whitestown, IN 46075 Phone: 877-732-2262 | |
Dr. Jennifer Lynn Hamm, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4750 E 450 S, Whitestown, IN 46075 Phone: 877-732-3431 Fax: 317-849-9179 | |
Ryan Drury, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4750 E 450 S, Whitestown, IN 46075 Phone: 877-732-3431 |